Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet

Autor: Lengfelder E, Lo-Coco F, Ades L, Montesinos P, Grimwade D, Kishore B, Ramadan SM, Pagoni M, Breccia M, Huerta AJ, Nloga AM, González-Sanmiguel JD, Schmidt A, Lambert JF, Lehmann S, Di Bona E, Cassinat B, Hofmann WK, Görlich D, Sauerland MC, Fenaux P, Sanz M, European LeukemiaNet

Publikováno v: Leukemia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

In 2008, a European registry of relapsed acute promyelocytic leukemia was established by the European LeukemiaNet. Outcome data were available for 155 patients treated with arsenic trioxide in first relapse. In hematological relapse (n = 104), 91% of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::e694886cd630b4623d9a491fd9a49bf5
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1303

Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy.

Autor: Labrador J; a Hospital Universitario de Burgos , Burgos , Spain., Luño E; b Department of Hematology , Hospital Universitario Central de Asturias , Oviedo , Spain., Vellenga E; c University Medical Center Groningen , University of Groningen , Groningen , The Netherlands., Brunet S; d Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and Jose Carreras Leukemia Research Institutes , Universitat Autònoma de Barcelona , Barcelona , Spain., González-Campos J; e Hospital Universitario Virgen del Rocío , Sevilla , Spain., Chillón MC; f University Hospital of Salamanca-Instituto de Investigación Biomédica de Salamanca , Salamanca , Spain.; g CIBERONC, Instituto Carlos III , Madrid , Spain., Holowiecka A; h Department of Haematology and BMT , Silesian Medical University , Katowice , Poland., Esteve J; i Hospital Clinic , Barcelona , Spain., Bergua J; j Hospital San Pedro de Alcántara , Cáceres , Spain., González-Sanmiguel JD; k Hospital Insular , Las Palmas , Spain., Gil C; l Hospital General de Alicante , Alicante , Spain., Tormo M; m Hospital Clínico Universitario de Valencia , Valencia , Spain., Salamero O; n Hospital Universitario Vall d´Hebron , Barcelona , Spain., Manso F; o Hospital General , Albacete , Spain., Fernández I; p Fundaleu , Buenos Aires , Argentina., de laSerna J; q Hospital 12 de Octubre , Madrid , Spain., Moreno MJ; r Hospital Virgen de la Victoria , Málaga , Spain., Pérez-Encinas M; s Hospital Clínico Universitario , Santiago de Compostela , Spain., Krsnik I; t Hospital Puerta de Hierro , Madrid , Spain., Ribera JM; u ICO-Hospital Universitari Germans Trias i Pujol, Josep Carreras Leukemia Research Institute , Universitat Autònoma de Barcelona , Barcelona , Spain., Cervera J; v Hematology Department , Hospital Universitari i Politécnic La Fe , Valencia , Spain., Calasanz MJ; g CIBERONC, Instituto Carlos III , Madrid , Spain.; w CIMA Lab Diagnostics , Pamplona , Spain.; x University of Navarra , Pamplona , Spain., Boluda B; g CIBERONC, Instituto Carlos III , Madrid , Spain.; v Hematology Department , Hospital Universitari i Politécnic La Fe , Valencia , Spain., Sobas M; y Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation , Wroclaw Medical University , Wroclaw , Poland., Lowenberg B; z Erasmus University Medical Center , Rotterdam , The Netherlands., Sanz MA; g CIBERONC, Instituto Carlos III , Madrid , Spain.; v Hematology Department , Hospital Universitari i Politécnic La Fe , Valencia , Spain.; aa Department of Medicine , University of Valencia , Valencia , Spain., Montesinos P; g CIBERONC, Instituto Carlos III , Madrid , Spain.; v Hematology Department , Hospital Universitari i Politécnic La Fe , Valencia , Spain.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2019 May; Vol. 60 (5), pp. 1146-1155. Date of Electronic Publication: 2018 Dec 11.